News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Genetic Signatures.
RELATED STOCKHEAD STORIES
News
In Case You Missed It: Rare earths on the rise, and coal seam gas pilot spudded
Health & Biotech
ASX Health Stocks: Genetic Signatures jumps 20pc on FDA update, Proteomics reveals new patent in Japan
Health & Biotech
ASX Health Stocks: Sub $50m market cap Austco nabs $7.4m contract, the biggest in its history
Health & Biotech
The Ethical Investor: Why Starpharma and these ASX biotechs could stop the next infectious disease outbreak
News
Rise and Shine: Everything you need to know before the ASX opens
Experts
MoneyTalks: Zip share price could quadruple while Genetic Signatures to triple, say these brokers
Experts
Dr Boreham’s Crucible: Three out of four quarters says trust your about gut about Genetic Signatures
Health & Biotech
ASX Health Stocks: New dawn for Alzheimer’s after Biogen’s landmark results; Cogstate soars by proxy
Health & Biotech
ASX Health Stocks: INOVIQ reports good study results; Mayne Pharma launches unique oral contraceptive
Health & Biotech
ScoPo’s Powerplays: Case of courage under fire for ASX health stocks
Experts
SocPo’s Powerplays: A few healthcare gems among the carnage
Health & Biotech
Check Up: Anteotech riding high with $1.9m refund, and Avecho inks supply agreement for CBD arthritis treatment
Health & Biotech
ScoPo’s Powerplays: ‘Light shining bright at the end of the tunnel’ as outlook turns positive for healthcare
Health & Biotech
ScoPo’s Powerplays: Reopening brings previously neglected health stocks into play
Health & Biotech
Dr Boreham’s Crucible: Testing times for Covid assay developers
Health & Biotech
ScoPo’s Powerplays: As focus turns to Delta variant, these ASX health stocks are profiting from COVID-19 testing
Health & Biotech
